Hepatitis E Virus Infections in Blood Donors, France
Pierre Gallian, Sébastien Lhomme, Yves Piquet, Karine Sauné, Florence Abravanel, Azzedine Assal, Pierre Tiberghien, and Jacques Izopet
Author affiliations: École des Hautes Études en Santé Publique, Marseille, France (P. Gallian); Etablissement Français du Sang Alpes Méditerranée, Marseille (P. Gallian); Institut National de la Santé et de la Recherche Médicale Unite 1043, Toulouse, France (S. Lhomme, K. Sauné, F. Abravanel, J. Izopet); Université Toulouse III Paul-Sabatier, Toulouse (S. Lhomme, K. Sauné, F. Abravanel, J. Izopet); Institut Fédératif de Biologie, Toulouse (S. Lhomme, K. Sauné, F. Abravanel, J. Izopet); Etablissement Français du Sang Aquitaine-Limousin, Bordeaux, France (Y. Piquet, A. Assal); Etablissement Français du Sang, La Plaine Saint-Denis, France (P. Tiberghien); Université de Franche-Comté, Besançon, France (P. Tiberghien)
Figure 2. Frequency of blood donations positive for hepatitis E virus (HEV) RNA, by location and donor age and sex, France, November 27, 2012–December 1, 2013. Comparisons between groups by using χ2 and Fisher exact tests showed no significant differences.
Page created: October 17, 2014
Page updated: October 17, 2014
Page reviewed: October 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.